AMICUS THERAPEUTICS, INC. (FOLD) Stock Profile — Insider Trades & Financials

Revenue$185.2M

Net Income$1.7M

EPS$0.00

Gross Margin85.7%

Market Cap$4.5B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Bradley Campbell

CEO & Executive Director

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

Founded: 2002
Employees: 508
Headquarters: PRINCETON, NJ, United States
Website

⚡

Core Efficiency

ROE?

0.62%

ROA?

0.18%

D/E Ratio?

2.46

Op. Margin?

8.61%

📊

Profitability Ratios

Net Margin?

0.91%

Loading company sections...

AMICUS THERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades

The morning brief, before the bell.

AMICUS THERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades